成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 5398-36-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 5398-36-7
Chemical Structure| 5398-36-7
Structure of 5398-36-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 5398-36-7 ]

Related Doc. of [ 5398-36-7 ]

Alternatived Products of [ 5398-36-7 ]
Product Citations

Product Details of [ 5398-36-7 ]

CAS No. :5398-36-7 MDL No. :MFCD00619079
Formula : C6H8N2O2S Boiling Point : -
Linear Structure Formula :- InChI Key :XHFUVBWCMLLKOZ-UHFFFAOYSA-N
M.W : 172.20 Pubchem ID :73216
Synonyms :

Calculated chemistry of [ 5398-36-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.33
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 42.6
TPSA : 93.45 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.58
Log Po/w (XLOGP3) : 1.16
Log Po/w (WLOGP) : 0.91
Log Po/w (MLOGP) : -0.16
Log Po/w (SILICOS-IT) : 1.5
Consensus Log Po/w : 1.0

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.78
Solubility : 2.88 mg/ml ; 0.0167 mol/l
Class : Very soluble
Log S (Ali) : -2.72
Solubility : 0.33 mg/ml ; 0.00192 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.41
Solubility : 6.67 mg/ml ; 0.0387 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.58

Safety of [ 5398-36-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5398-36-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5398-36-7 ]
  • Downstream synthetic route of [ 5398-36-7 ]

[ 5398-36-7 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 5398-36-7 ]
  • [ 61830-21-5 ]
YieldReaction ConditionsOperation in experiment
79% at 20 - 80℃; for 13.5 h; General procedure: 2-Aminothiazoles (0.1 mol) were dissolved in the least amount of glacial acetic acid, and then bromine (0.11 mol) was added drop-wise with continuous stirring at room temperature. The mixture was heated at 80 °C for 90 min then stirred at room temperature for 12 h. The mixture was filtered and washed with water. The precipitate was heated in water, and the aqueous solution was alkalized by ammonia, filtered, washed with water and then dried. Crystals were formed from ethanol/water to give the 5-bromothiazol-2-amine compounds 3a–f.
Reference: [1] Medicinal Chemistry Research, 2015, vol. 24, # 8, p. 3194 - 3211
[2] Journal of Medicinal Chemistry, 1977, vol. 20, p. 572 - 576
[3] Tetrahedron Letters, 2002, vol. 43, # 39, p. 7051 - 7053
[4] Patent: US2007/281979, 2007, A1, . Location in patent: Page/Page column 22
[5] Patent: US2007/4700, 2007, A1, . Location in patent: Page/Page column 23
  • 2
  • [ 5398-36-7 ]
  • [ 70-23-5 ]
  • [ 61830-21-5 ]
Reference: [1] Patent: US5705516, 1998, A,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Pharmaceutical Intermediates of
[ 5398-36-7 ]

Acotiamide Intermediates

Chemical Structure| 877997-99-4

[ 877997-99-4 ]

Methyl 2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxylate

; ;